Design, synthesis, and biological activities of novel Ligustrazine derivatives

A series of novel Ligustrazine derivatives was designed, synthesized, and assayed for their protective effects on damaged ECV-304 cells and antiplatelet aggregation activities. The results showed that most Ligustrazine derivatives exhibited lower EC50 values for protective effects on the ECV-304 cells damaged by hydrogen peroxide in comparison with Ligustrazine. And some Ligustrazine derivatives presented better antiplatelet aggregation activities than Ligustrazine. The derivatives containing the bisphenylmethyl pharmacophore (7a–c) exhibited highest potency. Compound 7a displayed most potential protective effects on the ECV-304 cells damaged by hydrogen peroxide, and compound 7c was found to be the most active antiplatelet aggregation agent. Structure–activity relationships were briefly discussed.

A series of novel Ligustrazine derivatives was designed and synthesized. Their protective effects on damaged ECV-304 cells and antiplatelet aggregation activities were reported.Figure optionsDownload as PowerPoint slide